News & Analysis as of

Animal Testing

Biomedical Research Advocacy

by Fox Rothschild LLP on

Like many other animal-related businesses universities, researchers, pharmaceutical companies, their suppliers, associated businesses and non-profit trade associations, are facing increasing scrutiny by the public who...more

“Come See Our World” Presented By Americans For Medical Progress

by Fox Rothschild LLP on

American for Medical Progress (AMP), “a nonprofit organization dedicated to protecting society’s investment in biomedical research,” just launched an important new educational tool for the public to see and understand the...more

ICCVAM Invites Comments Regarding its Preparation of a Strategic Roadmap: New Approaches to Evaluate the Safety of Chemicals and...

by Bergeson & Campbell, P.C. on

On May 8, 2016, the U.S. Environmental Protection Agency (EPA) announced its invitation for public input regarding the “Strategic Roadmap: New Approaches to Evaluate the Safety of Chemicals and Medical Products” (Roadmap),...more

International Product Liability Review - Issue 65

by Hogan Lovells on

The International Product Liability Review provides quality updates and comment from around the world on legal developments in the field of product liability and product safety. Please see full Publication below for more...more

EPA Announces Start of Voluntary Pilot Program to Reduce Animal Testing

by Bergeson & Campbell, P.C. on

On December 20, 2016, the U.S. Environmental Protection Agency (EPA) announced the start of a pilot program to evaluate the usefulness and acceptability of a mathematical tool (the GHS Mixtures Equation), which is used in the...more

Drug and Device Companies May Soon Face Less Burdensome FDA Approval Process

by Buchalter on

On July 10, 2015, Congress passed H.R. 6, the 21st Century Cures Act, with a bipartisan vote of 344 to 77. The 352-page bill seeks to make the U.S. Food and Drug Administration (FDA) drug and device approval process less...more

Avelox® Approved for Plague Under Animal Efficacy Rule

by McGuireWoods LLP on

On May 8, 2015, FDA approved a new antibacterial treatment for plague, Avelox® (moxifloxacin). Plague is a deadly infectious disease caused by the enterobacteria Yersinia pestis, which can be spread in the air, by direct...more

Health Alert (Australia) - April 13, 2015

by DLA Piper on

In This Issue: Judgments; Legislation; and Reports. Excerpt from Reports: 27 March 2015 - Public consultation opens on draft Principles and guidelines for the care and use of non-human primates for scientific...more

EPA Releases Draft Guidelines for Endocrine Testing

by Bergeson & Campbell, P.C. on

On January 30, 2015, the U.S. Environmental Protection Agency (EPA) released drafts of new guidelines for animal testing of the endocrine disrupting effects of pesticides and other chemicals. ...more

Global Food, Drug and Medical Device Newsletter

by K&L Gates LLP on

In this issue: Legislative Updates: - (i) USA - (ii) EU - (iii) China - (iv) Australia - (v) Japan. - Featured Articles: - (i) Caffeinated Energy Drinks - a Global Perspective - (ii)...more

China Strengthens Oversight of Human Subjects Research

by Ropes & Gray LLP on

On July 15, 2013, China National Health and Family Planning Commission (the “Commission”) published the draft Administrative Measures on Medical Research Involving Human Subjects (the “Draft Measures”) and is seeking public...more

New EU Regulation on Cosmetic Products Enters Into Force

by McDermott Will & Emery on

On 11 July 2013 Regulation (EC) No 1223/2009 (Regulation) will replace the Cosmetics Directive of 1976 that used to rule cosmetic products in the European Union. Major aims of the Regulation are health protection, animal...more

Blanket Ban on Animal Testing on Cosmetics Enters into Force

by K&L Gates LLP on

The European Union (EU), through a Commission Communication adopted yesterday, has decided to implement a total marketing ban on cosmetic products and ingredients tested on animals as from March 11, 2013. This ban will be...more

13 Results
|
View per page
Page: of 1
Cybersecurity

"My best business intelligence,
in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.